Teriparatide vs. Alendronate as a treatment for osteoporosis: Changes in biochemical markers of bone turnover, BMD and quality of life

BACKGROUND: We studied the use of teriparatide in postmenopausal women with severe osteoporosis. MATERIAL/METHODS: Two groups (A and B) of patients affected by severe osteoporosis (T-score ⩽−2.5 at bone mineral density were analyzed and 2 vertebral fractures on radiograph). Group A was treated for 1...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Panico, Annalisa, Lupoli, Gelsy Arianna, Marciello, Francesca, Lupoli, Roberta, Cacciapuoti, Marianna, Martinelli, Addolorata, Granieri, Luciana, Iacono, Daniela, Lupoli, Giovanni
Формат: Artigo
Язык:Inglês
Опубликовано: International Scientific Literature, Inc. 2011
Предметы:
Clinical Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3539612/
https://ncbi.nlm.nih.gov/pubmed/21804463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.881905
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы